Yahoo Web Search

Search results

1. • 

     Earnings call: Lineage Cell Therapeutics reports positive OpRegen trial results

     Investing.com· 5 days ago

     The therapy showed an average gain in visual acuity, contrasting with the typical loss experienced...

2. • 

     Bright Sight Eye Care to offer optical services, products in Georgetown

     Community Impact· 6 days ago

     The new clinic will provide glasses, contacts and eye disease treatment.

3. • 

     Liberty-based human tissue bank claims competitor is spreading lies - Kansas City Business Journal

     The Business Journals· 2 days ago

     The business of human tissue banking and manufacturing is supposed to be about creating scientific...

4. • Lineage Cell Therapeutics Q1 2024 Earnings: Aligns with EPS Proj

     Guru Focus· 5 days ago

     On May 9, 2024, Lineage Cell Therapeutics Inc (LCTX, Financial) disclosed its financial results for the first quarter of 2024 through an 8-K filing. The clinical-stage biotechnology company, ...

5. • EyePoint Pharmaceuticals Q1 2024 Earnings: Revenue Surpasses Est

     Guru Focus· 5 days ago

     The company, known for its innovative ophthalmic products, reported a significant increase in revenue, surpassing analyst expectations for the quarter. EyePoint Pharmaceuticals Inc is a pioneer ...

6. • 

     The most innovative Mother’s Day campaigns from Dove, MoneyGram, DoorDash & more

     The Drum· 5 days ago

     From heartwarming reunions facilitated by DoorDash to MullenLowe planting career opportunities for...

7. • Lineage Cell Therapeutics Q1 2024 Earnings: Aligns with EPS Projections Amidst Revenue Declines

     GuruFocus.com via Yahoo Finance· 5 days ago

     Their diverse pipeline includes therapies like OpRegen for dry age-related macular degeneration, OPC1 for acute spinal cord injuries, and several other ...

8. • 

     Your Pickleball Checklist

     Prevention· 7 days ago

     Pickleball just can’t seem to stop growing. Part of its mass appeal is its unique accessibility to all ages and skill levels, with small courts that...

9. • Qsemble Capital Management LP Purchases Shares of 239 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

     ETF DAILY NEWS· 1 day ago

     Qsemble Capital Management LP acquired a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the 4th quarter, according to its most recent 13F filing ...

10. • Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) to Post FY2028 Earnings of $0.16 Per Share, HC...

      ETF DAILY NEWS· 1 day ago

      Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX – Free Report) – Investment analysts at HC Wainwright lowered their FY2028 earnings per share (EPS) estimates for shares of Lineage Cell Therapeutics ...